IOL CHEMICALS & PHARM. | COLINZ LABOR | IOL CHEMICALS & PHARM./ COLINZ LABOR |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 20.7 | 63.7% | View Chart |
P/BV | x | 1.5 | 1.2 | 124.2% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. COLINZ LABOR |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
COLINZ LABOR Mar-23 |
IOL CHEMICALS & PHARM./ COLINZ LABOR |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 61 | 877.7% | |
Low | Rs | 272 | 24 | 1,158.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 28.3 | 1,336.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.8 | 1,306.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 2.3 | 1,357.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 32.3 | 795.1% | |
Shares outstanding (eoy) | m | 58.71 | 2.52 | 2,329.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.5 | 71.5% | |
Avg P/E ratio | x | 17.1 | 23.3 | 73.2% | |
P/CF ratio (eoy) | x | 12.8 | 18.2 | 70.5% | |
Price / Book Value ratio | x | 1.6 | 1.3 | 120.2% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 107 | 22,269.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 29 | 5,808.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 71 | 31,143.6% | |
Other income | Rs m | 256 | 2 | 14,889.5% | |
Total revenues | Rs m | 22,427 | 73 | 30,760.1% | |
Gross profit | Rs m | 2,257 | 6 | 37,055.8% | |
Depreciation | Rs m | 462 | 1 | 35,782.9% | |
Interest | Rs m | 165 | 1 | 31,673.1% | |
Profit before tax | Rs m | 1,887 | 6 | 31,441.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1 | 34,866.2% | |
Profit after tax | Rs m | 1,391 | 5 | 30,446.4% | |
Gross profit margin | % | 10.2 | 8.6 | 119.0% | |
Effective tax rate | % | 26.2 | 23.7 | 110.6% | |
Net profit margin | % | 6.3 | 6.4 | 97.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 78 | 12,337.6% | |
Current liabilities | Rs m | 5,025 | 19 | 26,644.8% | |
Net working cap to sales | % | 20.9 | 83.6 | 25.1% | |
Current ratio | x | 1.9 | 4.2 | 46.3% | |
Inventory Days | Days | 43 | 35 | 123.0% | |
Debtors Days | Days | 8 | 581 | 1.4% | |
Net fixed assets | Rs m | 11,017 | 24 | 45,982.5% | |
Share capital | Rs m | 587 | 25 | 2,330.7% | |
"Free" reserves | Rs m | 14,490 | 56 | 25,783.1% | |
Net worth | Rs m | 15,077 | 81 | 18,524.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 102 | 20,216.9% | |
Interest coverage | x | 12.5 | 12.5 | 99.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.7 | 154.0% | |
Return on assets | % | 7.5 | 5.0 | 151.0% | |
Return on equity | % | 9.2 | 5.6 | 164.2% | |
Return on capital | % | 13.6 | 8.0 | 169.8% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 4 | 30,340.0% | |
From Investments | Rs m | -1,200 | NA | -1,333,333.3% | |
From Financial Activity | Rs m | -41 | 1 | -3,702.7% | |
Net Cashflow | Rs m | -18 | 5 | -351.8% |
Indian Promoters | % | 48.2 | 66.0 | 73.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 34.0 | 152.4% | |
Shareholders | 130,003 | 2,929 | 4,438.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | COLINZ LABOR | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | -1.89% | -0.44% |
1-Month | -4.43% | 0.00% | 2.15% |
1-Year | -4.01% | -0.51% | 49.82% |
3-Year CAGR | -11.98% | 64.26% | 14.21% |
5-Year CAGR | 15.37% | 43.14% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the COLINZ LABOR share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of COLINZ LABOR the stake stands at 66.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of COLINZ LABOR.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
COLINZ LABOR paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of COLINZ LABOR.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.